. 2023 Mar 28;12(3):455–465. doi: 10.21037/tau-23-128

Table 2. Top 10 most active institutions in targeted therapy for renal cancer as measured by the total number of publications from 2006 to 2022.

Ranking	Institute	Country	Number of documents	%
1^st	Harvard University	United States	65	5.72
2^nd	Udice French research universities	France	54	4.75
3^rd	University of Texas System	United States	49	4.31
4^th	Unicancer	France	45	3.96
5^th	University of California System	United States	45	3.96
6^th	Dana Farber Cancer Institute	United States	41	3.60
7^th	Assistance Publique Hopitaux Paris	France	38	3.34
8^th	University of London	England	37	3.25
9^th	Harvard Medical School	United States	36	3.16
10^th	Netherlands Cancer Institute	Netherlands	31	2.72